Frailty Clinical Trial - Frailty of Elderly With Valvular Heart Disease &

Status Recruiting

Clinical Trial Summary

Despite the rapid development of medical and nursing technology, the prognosis of valvular heart disease has been greatly improved. However, compared with young patients, the mortality and adverse event rate of elderly patients with valvular heart disease are still high, surgical complications are more frequent and hospitalization time is longer. The complexity of valvular heart disease and the poor prognosis in the elderly forces us to continue to look for other potential prognostic factors. In addition to the adverse outcomes caused by disease factors, elderly patients with valvular heart disease also have the gradual decline of physiological and psychological reserve function caused by age factors. These adverse outcomes include osteopenia, disability, prolonged hospitalization and even death are all closely related to frailty. Frailty is 'a biologic syndrome of decreased reserve and resistance to stressors, resulting from cumulative declines across multiple physiologic systems, and causing vulnerability to adverse outcomes. The essence of frailty is the decline of individual resistance, which eventually leads to the increase of individual brittleness and susceptibility to adverse health outcomes. At present, the research in the field of elderly vulnerable groups of cardiovascular disease in China started late, mostly focusing on the study of pathological mechanism, the introduction of evaluation tools, conceptual analysis and so on. Almost all of the existing studies are about the debilitation status of elderly patients with heart valve disease, and most of them mainly try to find the influencing factors of debilitation from the aspects of patients' physical diseases, ignoring the impact of factors such as the mental health status of the elderly on debilitation, there are few reports of short-term adverse events in elderly patients with valvular heart disease. This study will analyze the influencing factors of the weakness of elderly patients with valvular diseases from the multi-dimensional aspects of demographic data, physical diseases, psychology and society, and track the short-term prognosis of patients with death, fall and unconventional rehospitalization, so as to provide a research basis for relevant research in the future.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05014750
Study type	Observational
Source	Shanghai Zhongshan Hospital
Contact	Zhiyun Shen, Master
Phone	8618317089276
Email	shen.zhiyun@zs-hospital.sh.cn
Status	Recruiting
Phase
Start date	September 1, 2021
Completion date	August 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04992286` - Detection, Evaluation and Monitoring of Frailties in the Elderly (FRAGING)	N/A
Enrolling by invitation	`NCT05009706` - Self-care in Older Frail Persons With Heart Failure Intervention	N/A
Completed	`NCT05529147` - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting	`NCT04444544` - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed	`NCT04061785` - Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women	N/A
Completed	`NCT04140890` - Supporting Habit Formation to Attenuate Prefrailty in Elders: Pilot Study	N/A
Recruiting	`NCT03141866` - Seated Physical Activity in Ageing	N/A
Completed	`NCT04888884` - Loss of Independence - a Rapid Alternative to Frailty Screening in a Swedish ED Setting
Recruiting	`NCT04145726` - Frailty In Thoracic Surgery for Esophageal Cancer
Recruiting	`NCT04717869` - Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Not yet recruiting	`NCT06022666` - PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.	N/A
Not yet recruiting	`NCT04514536` - Evaluation of a Health Monitoring Platform for Elderly in Home Care Context	N/A
Completed	`NCT01126723` - Effects of Tai Chi on Frailty in Elderly Adults	N/A
Completed	`NCT00183040` - HORMA: Hormonal Regulators of Muscle and Metabolism in Aging	Phase 2
Active, not recruiting	`NCT05961319` - Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Enrolling by invitation	`NCT05047731` - Antihypertensive Deprescribing in Long-term Care	N/A
Completed	`NCT04956705` - Vitamin D and Calcium Supplementation at Danish Nursing Homes	N/A
Recruiting	`NCT03824106` - Frailty Rehabilitation	Phase 4
Recruiting	`NCT04518423` - Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People
Completed	`NCT04087343` - Strength on Wheels: A Meal Delivery and Exercise Intervention for Homebound Older Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms